Dr Oz links obesity to chronic disease surge, says GLP-1s can 'jumpstart' better health

Dr Oz links obesity to chronic disease surge, says GLP-1s can 'jumpstart' better health

GLP-1 Prescriptions Rise as U.S. Obesity Rates Show Modest Decline, New Data Indicates

New data from EPIC Research shows that GLP-1 medications like Ozempic and Wegovy are having a population-wide impact on obesity rates. As pr

Study Finds GLP-1 Drug Users Show Decreased Physical Activity Levels

A new study presented by doctors at HSHS Saint John's Hospital in Illinois found that people taking GLP-1 drugs like Ozempic and Wegovy sign

Obesity care's next generation will combine GLP-1 drugs with personalized therapies and advanced procedures

The article discusses how GLP-1 drugs like Ozempic, Wegovy, and Zepbound have transformed obesity treatment, but experts predict the future

Health tech companies rush to market 'GLP-1 ready' products as weight loss drug trend grows

This article from Verge's Optimizer newsletter examines how health tech companies are marketing products specifically to GLP-1 drug users (p

Experts warn easy access to GLP-1 drugs may increase eating disorder risks

Experts are raising concerns that the widespread availability of GLP-1 drugs (like Ozempic and Wegovy) through telemedicine and oral formula